Get the Stockscreener App
0.5647
5.16%
0.0277
Pre-market:
.55
-0.0147
-2.60%
Adicet Bio Inc stock is traded at $0.5647, with a volume of 1.71M.
It is up +5.16% in the last 24 hours and down -18.19% over the past month.
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.
See More
Previous Close:
$0.537
Open:
$0.5432
24h Volume:
1.71M
Relative Volume:
0.93
Market Cap:
$86.54M
Revenue:
$24.99M
Net Income/Loss:
$-118.64M
P/E Ratio:
-0.4311
EPS:
-1.31
Net Cash Flow:
$-100.25M
1W Performance:
-6.04%
1M Performance:
-18.19%
6M Performance:
-28.61%
1Y Performance:
-44.36%
1-Day Range:
$0.535
$0.5719
1-Week Range:
$0.525
$0.6969
52-Week Range:
$0.4471
$1.1228
Adicet Bio Inc Stock (ACET) Company Profile
Name
Adicet Bio Inc
Sector
Industry
Phone
617-482-2333
Address
131 DARTMOUTH STREET, BOSTON
Compare ACET with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACET
Adicet Bio Inc
|
0.5647 | 82.30M | 24.99M | -118.64M | -100.25M | -1.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Adicet Bio Inc Stock (ACET) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-30-24 | Resumed | Guggenheim | Buy |
| Sep-11-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jun-27-23 | Downgrade | Guggenheim | Buy → Neutral |
| Jun-27-23 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Jun-01-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-21-22 | Initiated | JP Morgan | Overweight |
| Mar-31-22 | Initiated | SMBC Nikko | Outperform |
| Mar-08-22 | Initiated | Truist | Buy |
| Mar-04-22 | Initiated | Jefferies | Buy |
| May-18-21 | Initiated | BTIG Research | Buy |
| Apr-23-21 | Initiated | H.C. Wainwright | Buy |
| Apr-14-21 | Initiated | Canaccord Genuity | Buy |
| Apr-08-21 | Initiated | Guggenheim | Buy |
| Nov-04-20 | Initiated | B. Riley Securities | Buy |
| Oct-27-20 | Initiated | JMP Securities | Mkt Outperform |
| Oct-16-20 | Initiated | Wedbush | Outperform |
View All
Adicet Bio Inc Stock (ACET) Latest News
What dividend safety rating applies to Adicet Bio Inc. (1IJA) stockJuly 2025 Fed Impact & Technical Buy Zone Confirmations - Newser
Retail Trends: How Adicet Bio Inc stock trades during market volatilityBond Market & Low Drawdown Momentum Trade Ideas - BỘ NỘI VỤ
How higher bond yields impact Adicet Bio Inc. (1IJA) stockJuly 2025 Gainers & Growth Focused Entry Reports - Newser
Can Adicet Bio Inc. (1IJA) stock sustain breakout momentumTrade Risk Summary & Real-Time Chart Pattern Alerts - Newser
Is Adicet Bio Inc. (1IJA) stock bottoming after sell offJuly 2025 Rallies & Real-Time Market Trend Scan - Newser
Why Adicet Bio Inc. (1IJA) stock remains top ratedJuly 2025 Selloffs & Short-Term High Return Ideas - Newser
What analyst consensus implies for Adicet Bio Inc. (1IJA) stockJuly 2025 Breakouts & Fast Entry Momentum Alerts - Newser
Views of Wall Street’s Leading Experts on Adicet Bio Inc - Setenews
Is Adicet Bio Inc. (1IJA) stock prepared for digital transitionTrade Volume Summary & Growth Focused Stock Reports - Newser
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
Adicet Bio (Nasdaq: ACET) issues options for 20,600 shares at $0.65 exercise price - Stock Titan
Perhaps timely catching Adicet Bio Inc (ACET) would be a good idea - Setenews
Brokerages Set Adicet Bio, Inc. (NASDAQ:ACET) PT at $7.33 - Defense World
Adicet Bio (ACET) Price Target Increased by 20.00% to 7.75 - MSN
Why Adicet Bio Inc. (1IJA) stock is listed among top recommendationsEarnings Recap Summary & Proven Capital Preservation Methods - newser.com
Why Adicet Bio Inc. (1IJA) stock is a strong analyst pickQuarterly Profit Report & Growth Focused Entry Reports - newser.com
Will Adicet Bio Inc. stock split again soonTrade Performance Summary & AI Powered Buy/Sell Recommendations - newser.com
Citizens reiterates Market Perform rating on Adicet Bio stock, citing fair valuation - Investing.com Canada
Citizens reiterates Market Perform rating on Adicet Bio stock, citing fair valuation By Investing.com - Investing.com South Africa
Can Adicet Bio Inc. (1IJA) stock stage a strong rebound this quarterEarnings Growth Report & Real-Time Chart Breakout Alerts - newser.com
Can Adicet Bio Inc. stock beat market expectations this quarterBull Run & Free Weekly Watchlist of Top Performers - newser.com
How institutional buying supports Adicet Bio Inc. stockJuly 2025 Pullbacks & Weekly Chart Analysis and Guides - newser.com
Historical volatility pattern of Adicet Bio Inc. visualized2025 EndofYear Setup & High Conviction Trade Alerts - newser.com
Will Adicet Bio Inc. stock benefit from green energy trendsPortfolio Risk Report & AI Driven Stock Movement Reports - newser.com
Will breakout in Adicet Bio Inc. lead to full recovery2025 Price Action Summary & Verified Momentum Stock Ideas - newser.com
Combining machine learning predictions for Adicet Bio Inc.July 2025 Opening Moves & Consistent Income Trade Ideas - newser.com
How Adicet Bio Inc. stock reacts to oil pricesBond Market & Verified High Yield Trade Plans - newser.com
An analyst sees good growth prospects for Adicet Bio Inc (ACET) - Setenews
[DEF 14A] Adicet Bio, Inc. Definitive Proxy Statement - Stock Titan
Adicet Bio Inc Stock (ACET) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.10%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):